{
  "id": "b03a1f3583646181",
  "title": "Immunome CEO Touts Phase 3 Desmoid Win , Near - Term FDA NDA Plan and Early IM - 1021 ADC Responses",
  "description": "20260214T213000Z",
  "content": "",
  "source": "dailypolitical.com",
  "source_url": "https://www.dailypolitical.com/2026/02/14/immunome-ceo-touts-phase-3-desmoid-win-near-term-fda-nda-plan-and-early-im-1021-adc-responses.html",
  "published_at": "20260214T213000Z",
  "fetched_at": "2026-02-15T00:30:56.287245+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.dailypolitical.com/2026/02/14/immunome-ceo-touts-phase-3-desmoid-win-near-term-fda-nda-plan-and-early-im-1021-adc-responses.html",
    "url_mobile": "",
    "title": "Immunome CEO Touts Phase 3 Desmoid Win , Near - Term FDA NDA Plan and Early IM - 1021 ADC Responses",
    "seendate": "20260214T213000Z",
    "socialimage": "",
    "domain": "dailypolitical.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}